Emergent BioSolutions Inc. (NYSE:EBS) and Valneva SE (Euronext Paris:VLA) today announced the initiation of a Phase 1 clinical trial in the U.S. to evaluate the safety and immunogenicity of VLA1601, their vaccine candidate against Zika virus.
Apple is launching medical clinics for its employees in the latest attempt by a large tech company to address the U.S.’s growing healthcare problem. The new project, called AC Wellness, is launching sometime in the spring, according to its new website.
AstraZeneca has carved off six inflammation and autoimmune assets to create a new biotech, Viela Bio. The startup put together a $250 million series A round and a management team from its parent company to guide the mix of clinical and preclinical programs forward.
A Maryland bill that would make the state a national test case for controlling prescription drug costs has garnered broad legislative support in Annapolis but could put the state on a legal collision course with the pharmaceutical industry.
The Inova Personalized Health Accelerator (IPHA) announced today that it will expand its free educational program designed to teach first-time healthcare technology entrepreneurs how to grow successful companies. The spring 2018 session will build on the curriculum provided during the fall 2017 program. Inova’s fall program supported 57 enrolled participants over a 14-week training period. Entrepreneurs interested in participating in the program are encouraged to apply via the IPHA web site (http://www.inovapha.org/for-entrepreneurs/training-program/ )
Researchers from theUniversity of Maryland School of Medicine (UMSOM) and the University of Maryland A. James Clark School of Engineering have developed a new military vehicle shock absorbing device that may protect troops from traumatic brain injury (TBI) after a land mine blast. Over the past 18 years of conflicts in Iraq and Afghanistan, more than 250,000 troops have suffered such injuries.
When: Wednesday, March 14, 2018 from 5:00 PM to 7:00 PM
Where: Bar Louie 150 Gibbs St Rockville, MD 20850
Join BioBuzz and founding sponsor The Johns Hopkins University Montgomery County Campus at Bar Louie on March 14th. The Johns Hopkins University Montgomery County Campus offers part-time graduate courses in biotechnology fields. Students attend classes in the evenings and on Saturdays, enabling them to hold full-time jobs during the day. Depending on the degree area, students can fully complete their coursework in Montgomery County. Other students take some courses in Baltimore and/ or online.
MIMETAS, the market leader in Organ-on-a-chip products, announced that the National Cancer Institute recently awarded them a phase 1 SBIR grant totally $300,000 to develop personalized prostate cancer-on-a-chip models that can more accurately reproduce the tumor micro-environment. MIMETAS has built a consortium with the University of Texas Health Science Center (UTHSC) and MD Anderson to build the next generation platform for cancer drug screening and personal therapy prediction.
The University of Maryland’s SGA will send a letter to Amazon supporting Montgomery County for the company’s second headquarters, called HQ2.
MedImmune Inc., the research and development arm of global drug giant AstraZeneca PLC, is spinning out a new company named Viela Bio with plans to create 100 jobs within the next three to five years.